Literature DB >> 25509985

An AF9/ENL-targted peptide with therapeutic potential in mixed lineage leukemias.

Nisha N Barretto, Dean S Karahalios, Dewen You, Charles S Hemenway.   

Abstract

Misregulation of transcription elongation is proposed to underlie the pathobiology of MLL leukemia. AF4, AF9, and ENL, common MLL fusion partners, are found in complex with positive transcription elongation factor b (P-TEFb). AF9 and its homolog ENL directly interact with AF4 within these complexes. Previously, we designed a peptide that mimics the AF9 binding domain of AF4 and reported that MLL leukemia cell lines are inhibited by it. Extending these studies, we have modified the peptide design in order to avoid recognition by proteases. The peptide is as effective as its predecessor in vitro and enhances survival in mice bearing MLL leukemia cell lines.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25509985      PMCID: PMC5172450     

Source DB:  PubMed          Journal:  J Exp Ther Oncol        ISSN: 1359-4117


  17 in total

1.  HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP.

Authors:  Bijan Sobhian; Nadine Laguette; Ahmad Yatim; Mirai Nakamura; Yves Levy; Rosemary Kiernan; Monsef Benkirane
Journal:  Mol Cell       Date:  2010-05-14       Impact factor: 17.970

2.  HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription.

Authors:  Nanhai He; Min Liu; Joanne Hsu; Yuhua Xue; Seemay Chou; Alma Burlingame; Nevan J Krogan; Tom Alber; Qiang Zhou
Journal:  Mol Cell       Date:  2010-05-14       Impact factor: 17.970

3.  Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia.

Authors:  J G Blanco; T Dervieux; M J Edick; P K Mehta; J E Rubnitz; S Shurtleff; S C Raimondi; F G Behm; C H Pui; M V Relling
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

4.  Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo.

Authors:  A Ho; S R Schwarze; S J Mermelstein; G Waksman; S F Dowdy
Journal:  Cancer Res       Date:  2001-01-15       Impact factor: 12.701

5.  MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia.

Authors:  Sara C Monroe; Stephanie Y Jo; Daniel S Sanders; Venkatesha Basrur; Kojo S Elenitoba-Johnson; Robert K Slany; Jay L Hess
Journal:  Exp Hematol       Date:  2010-09-18       Impact factor: 3.084

6.  A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription.

Authors:  Akihiko Yokoyama; Min Lin; Alpana Naresh; Issay Kitabayashi; Michael L Cleary
Journal:  Cancer Cell       Date:  2010-02-17       Impact factor: 31.743

7.  hDOT1L links histone methylation to leukemogenesis.

Authors:  Yuki Okada; Qin Feng; Yihui Lin; Qi Jiang; Yaqiang Li; Vernon M Coffield; Lishan Su; Guoliang Xu; Yi Zhang
Journal:  Cell       Date:  2005-04-22       Impact factor: 41.582

8.  Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes.

Authors:  Debabrata Biswas; Thomas A Milne; Venkatesha Basrur; Jaehoon Kim; Kojo S J Elenitoba-Johnson; C David Allis; Robert G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-06       Impact factor: 11.205

9.  The synthetic peptide PFWT disrupts AF4-AF9 protein complexes and induces apoptosis in t(4;11) leukemia cells.

Authors:  R S Srinivasan; J B Nesbit; L Marrero; F Erfurth; V F LaRussa; C S Hemenway
Journal:  Leukemia       Date:  2004-08       Impact factor: 11.528

10.  Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group.

Authors:  Joanne M Hilden; Patricia A Dinndorf; Sharon O Meerbaum; Harland Sather; Doojduen Villaluna; Nyla A Heerema; Ron McGlennen; Franklin O Smith; William G Woods; Wanda L Salzer; Helen S Johnstone; Zoann Dreyer; Gregory H Reaman
Journal:  Blood       Date:  2006-03-23       Impact factor: 22.113

View more
  1 in total

Review 1.  The molecular mechanics of mixed lineage leukemia.

Authors:  R K Slany
Journal:  Oncogene       Date:  2016-02-29       Impact factor: 9.867

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.